NIH (SBIR/STTR), FDA (SBIR Only) and CDC (SBIR Only)

There will be no further training until after October 1, 2022.  Check sbir.gov/events for other training opportunities outside of Minnesota.

Every project and team is different, therefore, our support to approved Accelerator firms is individualized and customized based on the project, the phase and the team.

The National Institutes of Health (NIH), Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) SBIR/STTR programs invest over 1 billion dollars into health and life science companies that are creating innovative technologies that align with NIH/FDA/CDC’s mission to improve health and save lives. A key objective is to translate promising technologies to the private sector and enable life-saving innovations to reach consumer markets.

NIH is the steward of medical and behavioral research for the Nation. Its mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.  The goals of the agency are as follows:

  1. to foster fundamental creative discoveries, innovative research strategies, and their applications as a basis for ultimately protecting and improving health;
  2. to develop, maintain, and renew scientific human and physical resources that will assure the Nation’s capability to prevent disease;
  3. to expand the knowledge base in medical and associated sciences in order to enhance the Nation’s economic well-being and ensure a continued high return on the public investment in research; and
  4. to exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of

In realizing these goals, the NIH provides leadership and direction to programs designed to improve the health of the Nation by conducting and supporting research:

  • in the causes, diagnosis, prevention, and cure of human diseases;
  • in the processes of human growth and development;
  • in the biological effects of environmental contaminants;
  • in the understanding of mental, addictive and physical disorders; and
  • in directing programs for the collection, dissemination, and exchange of information in medicine and health, including the development and support of medical libraries and the training of medical librarians and other health information specialists.

Review the Omnibus Solicitations (Parent Announcements) below along with the Program Descriptions and Research Topics to understand the awarding components (Institutes), their topics of interest, and staff contacts. For topics that require additional funding to reach the marketplace, please refer to our list of SBA approved waiver eligible topics.

NOTE:  NIH issues FOAs based on whether the proposed project meets the definition of a clinical trial or not.  Be sure to select the correct FOA for your project.

Title  Notice/FOA Number  Organization Release Date  Due Date(s) Expiration Date 
PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) PA-22-177 OD 06/02/2022 Standard dates apply. (see announcement for full details) 04/06/2023
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-22-178 OD 06/02/2022 Standard dates apply…(see announcement for full details) 04/06/2023
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-22-179 OD 06/02/2022 Standard dates apply…(see announcement for full details) 04/06/2023
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-22-176 OD 06/02/2022 Standard dates apply …(see announcement for full details) 04/06/2023